COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?
Joint Authors
Yin, Yow Hui
Suet-May, Chow
Sin-Yee, Kuok
Qing, Lee Jia
Pey-Wen, Goh
Singh, Harleen Kaur A/P Ranjit
Zhi-Zheng, Timothy Tan
Foo, Jhi-Biau
Hamzah, Sharina
Sellappans, Renukha
Source
Sudan Journal of Medical Sciences
Issue
Vol. 17, Issue 4 (31 Dec. 2022), pp.498-538, 41 p.
Publisher
Omdurman Islamic University Faculty of Medicine
Publication Date
2022-12-31
Country of Publication
Sudan
No. of Pages
41
Main Subjects
Pharmacy, Health & Medical Sciences
Abstract EN
Coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has impacted the lives and wellbeing of many people.
This globally widespread disease poses a significant public health concern that urges to discover an effective treatment.
This review paper discusses the effectiveness of repurposed drugs used to treat COVID-19 and potential novel therapies for COVID-19.
Among the various repurposed drugs, remdesivir is the only agent approved by the Food and Drug Administration (FDA) to treat COVID-19.
On the other hand, several drugs have been listed in the Emergency Use Authorization (EUA) by the FDA to treat COVID-19, including casirivimab and imdevimab, baricitinib (in combination with remdesivir), bamlanivimab, tocilizumab, and IL-6 inhibitors.
In addition, in vitro and clinical studies have suggested cepharanthine, sotrovimab, and XAV-19 as potential treatments to manage COVID-19.
Due to inadequate understanding of COVID-19 and the rapid mutation of SARS-CoV-2, COVID-19 remains a threat to global public health, with vaccination considered the most effective method to decrease COVID-19 transmission currently.
Nevertheless, with the intense efforts of clinical researchers globally, more promising treatments for COVID-19 will be established in the future.
American Psychological Association (APA)
Suet-May, Chow& Sin-Yee, Kuok& Qing, Lee Jia& Pey-Wen, Goh& Singh, Harleen Kaur A/P Ranjit& Zhi-Zheng, Timothy Tan…[et al.]. 2022. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences،Vol. 17, no. 4, pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
Modern Language Association (MLA)
Suet-May, Chow…[et al.]. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences Vol. 17, no. 4 (2022), pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
American Medical Association (AMA)
Suet-May, Chow& Sin-Yee, Kuok& Qing, Lee Jia& Pey-Wen, Goh& Singh, Harleen Kaur A/P Ranjit& Zhi-Zheng, Timothy Tan…[et al.]. COVID-19 : how effective are the repurposed drugs and novel agents in treating the infection?. Sudan Journal of Medical Sciences. 2022. Vol. 17, no. 4, pp.498-538.
https://search.emarefa.net/detail/BIM-1491298
Data Type
Journal Articles
Language
English
Notes
Text in English ; abstracts in .
Record ID
BIM-1491298